<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/378" />
  <subtitle />
  <id>http://repository.usmf.md:80/handle/20.500.12710/378</id>
  <updated>2026-04-08T21:07:23Z</updated>
  <dc:date>2026-04-08T21:07:23Z</dc:date>
  <entry>
    <title>Influenţa eficacităţii trimetazidinei în tratamentul complex al bronhopneumopatiei cronice obstructive asociate cu cardiopatia ischemică</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/4895" />
    <author>
      <name>Condaruc, Natalia</name>
    </author>
    <author>
      <name>Butorov, Valentina</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/4895</id>
    <updated>2019-06-25T21:51:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Influenţa eficacităţii trimetazidinei în tratamentul complex al bronhopneumopatiei cronice obstructive asociate cu cardiopatia ischemică
Authors: Condaruc, Natalia; Butorov, Valentina
Abstract: COPD associated with ischemic coronary disease is not only a medical problem, but also a&#xD;
socio-economic one, which tends to affect younger people, physically active. Treatment of&#xD;
associated pathology still remains a current direction in contemporary medicine.&#xD;
The study included 52 patients with II degree of COPD, associated with ischemic coronary&#xD;
disease. The patients were investigated by ECG, Hollter, echocardiography and spirography.&#xD;
Combined treatment with trimetazidine was established to be more efficient versus the&#xD;
comparison group.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
BPCO asociată cu CI reprezintă nu doar o problemă medicală, dar şi social-economică&#xD;
importantă, care tinde să afecteze populaţia tot mai tânără, aptă de muncă, tratamentul patologiei&#xD;
asociate rămânând o direcţie actuală în medicina contemporană.&#xD;
Studiul a inclus 52 pacienti cu BPCO gr.II asociată cu CI cărora li s-a evaluat ECG, ECGHollter,&#xD;
ecocardiografia şi spirografia. S-a stabilit eficacitatea mai pronunţată a tratamentului&#xD;
combinat cu trimetazidină prin ameliorarea indicilor clinici la pacienţii din lotul respectiv versus&#xD;
celui de comparaţie.
Description: Catedra Medicina Internă Nr.3, USMF „N. Testemiţanu”</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Aspectele clinico-farmacologice ale perindoprilului în tratamentul cordului pulmonar cronic</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/4894" />
    <author>
      <name>Butorov, Serghei</name>
    </author>
    <author>
      <name>Gonciar, Veaceslav</name>
    </author>
    <author>
      <name>Condaruc, Natalia</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/4894</id>
    <updated>2019-06-25T21:51:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Aspectele clinico-farmacologice ale perindoprilului în tratamentul cordului pulmonar cronic
Authors: Butorov, Serghei; Gonciar, Veaceslav; Condaruc, Natalia
Abstract: The study included 46 patients with COPD complicated with CPH, treated with ACE&#xD;
inhibitor - perindopril associated with basic therapy. It was found that the inclusion of&#xD;
perindopril in the complex treatment of patients with COPD complicated by CPH improves the&#xD;
clinical course of disease, beneficially acting on indices of central and intracardiac&#xD;
hemodynamics and on cardiac arrhythmias.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
Studiul a inclus 46 pacienţi cu BPCO complicată cu CPC, cărora li s-a efectuat tratamentul&#xD;
cu inhibitorul ECA – perindopril asociat cu terapia de bază. S-a constatat că includerea&#xD;
perindoprilului în tratamentul complex al pacienţilor cu BPCO complicat cu CPC ameliorează&#xD;
evoluţia clinică a maladiei, acţionează benefic asupra indicilor hemodinamicii centrale şi&#xD;
intracardiace, şi asupra tulburărilor de ritm cardiac.
Description: Catedra Farmacologie şi Farmacie Clinică, USMF „N. Testemiţanu”&#xD;
Catedra Medicina Internă</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Eficacitatea activităţii de reabilitare în optimizarea tratamentului de recuperare al pacienţilor cu bronhopneumopatie cronică obstructivă</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/4893" />
    <author>
      <name>Butorov, Ivan</name>
    </author>
    <author>
      <name>Arama, Maria</name>
    </author>
    <author>
      <name>Butorov, Serghei</name>
    </author>
    <author>
      <name>Condaruc, Natalia</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/4893</id>
    <updated>2019-06-25T21:51:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Eficacitatea activităţii de reabilitare în optimizarea tratamentului de recuperare al pacienţilor cu bronhopneumopatie cronică obstructivă
Authors: Butorov, Ivan; Arama, Maria; Butorov, Serghei; Condaruc, Natalia
Abstract: The study included 36 patients with moderate degree of COPD, with a stable evolution. A&#xD;
program of physical and complementary therapy was elaborated as a recovery treatment. It was&#xD;
established a significant clinico-functional effect, manifested by reduced bronchial obstruction&#xD;
syndrome and improvement of the quality of life.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
Au fost examinaţi 36 pacienţi cu BPCO de gravitate medie cu evoluţie stabilă. S-a elaborat&#xD;
un program complex de terapie fizică şi complementară pentru tratamentul de recuperare. S-a&#xD;
stabilit un efect clinico-funcţional semnificativ, care s-a manifestat prin diminuarea gravităţii&#xD;
sindromului bronhoobstructiv şi ameliorarea calităţii vieţii.
Description: Departamentul Medicina Internă. Catedra Boli ocupaţionale, USMF “N. Testemiţanu”</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Tromboembolismul pulmonar la pacienţii cu factori de risc</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/4897" />
    <author>
      <name>Muravca, Alexei</name>
    </author>
    <author>
      <name>Anghel, Tatiana</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/4897</id>
    <updated>2019-06-25T21:51:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Tromboembolismul pulmonar la pacienţii cu factori de risc
Authors: Muravca, Alexei; Anghel, Tatiana
Abstract: Pulmonary thromboembolism is a multifactorial disease, influenced by the interaction of&#xD;
genetic and acquired risk factors. Almost 80-90% of cases of DVT detailed research may reveal&#xD;
at least one risk factor. Risk factors interact with one another, acting synergistically and&#xD;
additively. Acquired “classic” risk factors– age, obesity; “risk periods” like surgery, trauma,&#xD;
immobilization, medical conditions, pregnancy, postpartum period, oral contraceptive use, not&#xD;
only predispose apparently healthy people to DTV, but trigger DTV on genetically prone land.&#xD;
&#xD;
&#xD;
&#xD;
Tromboembolismul pulmonar (TEAP) reprezintă o afecţiune multifactorială, fiind&#xD;
influenţat de interacţiunea unor factori de risc genetici şi dobândiţi. Aproape 80-90% din cazurile&#xD;
de TVP la o cercetare amănunţită poate evidenţia cel puţin un factor de risc. Factorii de risc&#xD;
interacţionează între ei, acţionând sinergic şi aditiv. Factorii „clasici” dobândiţi de risc - vârsta,&#xD;
obezitatea; “perioadele de risc” reprezentate de intervenţii chirurgicale, traumatisme,&#xD;
imobilizare, afecţiuni medicale, sarcină, perioada postpartum, utilizarea contraceptivelor orale, &#xD;
nu numai predispun persoane aparent sănătoase la TVP, dar reprezintă trigger pentru TVP pe un&#xD;
teren predispus genetic
Description: (Conducător ştiinţific – Brocovschi Victoria, asistent universitar)&#xD;
Clinica medicală N 2, USMF „Nicolae Testemiţanu”</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

